Literature DB >> 27311894

Synthesis and cytotoxic activities of semisynthetic zearalenone analogues.

Kwanruthai Tadpetch1, Benyapa Kaewmee2, Kittisak Chantakaew2, Kawalee Kantee2, Vatcharin Rukachaisirikul2, Souwalak Phongpaichit3.   

Abstract

Zearalenone is a β-resorcylic acid macrolide with various biological activities. Herein we report the synthesis and cytotoxic activities of 34 zearalenone analogues against human oral epidermoid carcinoma (KB) and human breast adenocarcinoma (MCF-7) cells as well as noncancerous Vero cells. Some zearalenone analogues showed moderately enhanced cytotoxic activities against the two cancer cell lines. We have discovered the potential lead compounds with diminished or no cytotoxicity to Vero cells. Preliminary structure-activity relationship studies revealed that the double bond at the 1' and 2' positions of zearalenone core was crucial for cytotoxic activities on both cell lines. In addition, for zearalenol analogues, the unprotected hydroxyl group at C-2 and an alkoxy substituent at C-4 played key roles on cytotoxic effects of both cell lines.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytotoxicity; Structure modification; Structure–activity relationship; Zearalenone

Mesh:

Substances:

Year:  2016        PMID: 27311894     DOI: 10.1016/j.bmcl.2016.06.007

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Microarray based gene expression analysis of Sus Scrofa duodenum exposed to zearalenone: significance to human health.

Authors:  Cornelia Braicu; Roxana Cojocneanu-Petric; Ancuta Jurj; Diana Gulei; Ionelia Taranu; Alexandru Mihail Gras; Daniela Eliza Marin; Ioana Berindan-Neagoe
Journal:  BMC Genomics       Date:  2016-08-17       Impact factor: 3.969

2.  In Vitro Evaluation of the Individual and Combined Cytotoxic and Estrogenic Effects of Zearalenone, Its Reduced Metabolites, Alternariol, and Genistein.

Authors:  Adrienn Balázs; Zelma Faisal; Rita Csepregi; Tamás Kőszegi; Balázs Kriszt; István Szabó; Miklós Poór
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.